Crosstalk Between Inflammasome Signalling and Epithelial-Mesenchymal Transition in Cancer: Mechanistic Insights, Context-Dependence, and Therapeutic Opportunities
Authors:
- Abdul L. ShakerdiASAbdul L. Shakerdi
- Emma FinneganEFEmma Finnegan
- Yin-Yin ShengYSYin-Yin Sheng
- Karlo VidovicKVKarlo Vidovic
- Jessica M LoganJLJessica M Logan
- Mark P. WardMWMark P. Ward
- Sharon A. O'TooleSOSharon A. O'Toole
- Cara M MartinCMCara M Martin
- Stavros SelemidisSSStavros Selemidis
- Doug BrooksDoug Brooks
- John J. O'LearyJOJohn J. O'Leary
- Prerna TewariPTPrerna Tewari
Preprint
- 12 September 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Epithelial-mesenchymal transition (EMT) and inflammasome signaling are interconnected processes which underpin tumour progression, metastasis, and therapeutic resistance. Inflammasomes such as NLRP3 encourage pro-inflammatory states (IL-1β, IL-18, NF-κB) and the activation of signalling pathways like TGF-β that promote mesenchymal traits crucial for EMT. EMT transcriptional programs can then in turn modulate the inflammasome via NF-κB/TGF-β signaling, creating self-perpetuating mechanisms of cellular plasticity and dysregulated therapeutic response. We have reviewed the mechanistic evidence for EMT–inflammasome crosstalk in cancer and discussed the potential therapeutic implications. The function of the ENT-inflammasome axis is clearly context-dependent, with the cancer type, stage, and the complexity of the tumour microenvironment heavily contributing. The between EMT and the inflammasome is an overlooked mechanism of tumour evolution and targeting inflammasomes like NLRP3, or their downstream signalling pathways offer a promising therapeutic avenue, with the therapeutic objective of reducing metastasis and overcoming drug resistance.Keywords
All Related Versions
- Version 1, 2025-09-12, Preprints
- Published version: Cells, 14 (20), 1594.
This publication has 126 references indexed in Scilit:
- Endometriosis Typology and Ovarian Cancer RiskJAMA, 2024
- Visualizing Dynamic Changes During TGF-β-Induced Epithelial to Mesenchymal Transition2022
- E3 ubiquitin ligase TRIM24 deficiency promotes NLRP3/caspase‐1/IL‐1β‐mediated pyroptosis in endometriosisCell Biology International, 2021
- A Spectrum of Cell States During the Epithelial-to-Mesenchymal Transition2020
- Absent in melanoma 2 suppresses epithelial‐mesenchymal transition via Akt and inflammasome pathways in human colorectal cancer cellsJournal of Cellular Biochemistry, 2019
- Fenofibrate improves renal function by amelioration of NOX‐4, IL‐18, and p53 expression in an experimental model of diabetic nephropathyJournal of Cellular Biochemistry, 2018
- Epigenetic regulation of epithelial–mesenchymal transitionCellular and Molecular Life Sciences, 2016
- IL‐1β Promotes Malignant Transformation and Tumor Aggressiveness in Oral CancerJournal of Cellular Physiology, 2014
- Review: Interstitial Lung Disease Associated With Systemic Sclerosis and Idiopathic Pulmonary Fibrosis: How Similar and Distinct?Arthritis & Rheumatology, 2014
- Oestrogen‐induced epithelial–mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosisThe Journal of Pathology, 2010